FDA approves centanafadine (Simtriyo) for the treatment of attention-deficit hyperactivity disorder.
What this means
Simtriyo is a pill for ADHD that works by increasing levels of key brain chemicals like norepinephrine, dopamine, and serotonin. The FDA has now approved it for treating ADHD in adults and children aged six and older. This provides a new, first-in-class medication option for patients with this condition.
